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 Abstract 
Background: Post-traumatic stress disorder (PTSD) is prevalent in approximately 12% of patients 
with cardiovascular disease (CVD) and such patients are at risk of further CVD morbidity and 
mortality. It is unknown whether CVD patients with cardiac and non-cardiac traumatic events leading 
to PTSD differ in medical comorbidities and psychiatric vulnerabilities. Our objective was to compare 
heart failure (HF) patients with cardiac and non-cardiac PTSD.   
Method: A population of HF patients from 3 hospitals underwent a two-step depression and anxiety 
screening process to identify potential mental health treatment needs. The post-traumatic stress 
disorder module of the Structured Clinical Interview for DSM-IV Axis-I disorders was used to 
classify trauma(s) exposure, and other disorders. The patients with PTSD were sub-divided by cardiac 
related traumas (e.g. myocardial infarction, sudden cardiac arrest) and non-cardiac related traumas 
(e.g. sexual abuse, interpersonal violence).  
Results: 10 patients met criteria for non-cardiac trauma and 18 patients met criteria for cardiac-
induced trauma. There were no significant differences in HF aetiology or severity nor cardiac 
comorbidities. Time since PTSD onset was significantly longer for those with non-cardiac PTSD. 
Among psychiatric comorbidities, alcohol and substance abuse disorders, as well as depression were 
more prevalent in the patients with non-cardiac PTSD.  
Conclusion: Cardiac related PTSD was associated with less alcohol and substance abuse disorders, 
and depression by comparison to their non-cardiac induced PTSD counterparts. Ongoing research is 
required to establish if cardiac-induced PTSD truly reflects a unique subtype of PTSD, and whether 
there are different treatment needs and therapeutic approaches for this subtype. 
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1. INTRODUCTION 
Post-traumatic stress disorder (PTSD) is associated 
with a higher risk of developing incident cardiovascular 
disease (CVD) [1]. Moreover, among populations with 
known or prevalent CVD, PTSD  is detected in 
approximately 12% (95% confidence interval [CI], 9%–
16%) of patients [2] and portends a poorer cardiovascular 
prognosis [2, 3]. However, past estimates of PTSD 
prevalence have generally not differentiated between CVD-
related and non-CVD traumas [2, 4]. Recently, Vilchinsky et 
al. [5] synthesized literature pertaining to PTSD following a 
CVD event or intervention (e.g. myocardial infarction [MI] 
or heart transplant), positing that cardiac-induced PTSD was 
a specific subtype of PTSD. The prevalence of PTSD 
induced by CVD ranges from 0 to 38% of patients [2, 5, 6]. 
These findings suggest high uncertainty in the prevalence of 
CVD-induced PTSD and perhaps raise questions as to the 
validity of a distinct PTSD phenotype. Moreover, the CVD-
induced PTSD hypothesis relies largely on information 
gleaned from acute coronary syndrome patients, even though 
PTSD is relatively common in patients with 
cardiomyopathies [7], heart transplant [8], implantable 
cardioverter defibrillator [9], coronary revascularization [10], 
and sudden cardiac arrest [11].  
Indeed, less is known about the ways in which 
cardiac-induced PTSD differs from other PTSD trauma onset 
in populations with CVD, such as variation in biomedical or 
psychiatric comorbidities or vulnerabilities. This is an 
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important limitation to reconcile given the public health 
importance of PTSD [6] and the preponderance to CVD in 
populations exposed to trauma including veterans [7, 12, 13]. 
Moreover, explicating differences between trauma sub-types 
may uncover discrete associations between PTSD subtypes 
and pertinent CVD risk factors. For example, prior research 
indicates PTSD post-acute coronary syndrome (ACS) is 
associated with lower CVD medication adherence [14]. 
Indeed, most information regarding PTSD and CVD pertains 
to ACS [2, 5], with less reported for heart transplant, and 
ventricular assist device populations, with no specific reports 
among heart failure (HF). This is an important limitation to 
overcome because of the burgeoning HF population 
worldwide [15], coupled with the adverse cardiovascular 
outcomes for HF patients with PTSD [7, 12, 13]. This study 
aims to compare the characteristics of HF patients with 




2.1 Population  
  This study reports data from HF patients 
participating in a HF self-management program (HFSMP) at 
3 public hospitals in the North and Western urban areas of 
Adelaide, South Australia (Queen Elizabeth Hospital, Royal 
Adelaide Hospital, Lyell McEwin Hospital). HFSMP nurses 
initiated a standardized screening protocol for depression, 
anxiety, and panic attack [16]. Patients in this study provided 
written consent. This study complies with the Declaration of 
Helsinki and the study approved by the human research 
ethics committee of the Queen Elizabeth and Lyell McEwin 
hospital (#HREC/12/TQEHLMH/188).  
 
2.2 Psychiatric assessments 
In this HFSMP screening consisted of assessment 
for depression, (Patient Health Questionnaire-9 items, PHQ-
9), anxiety (Generalized Anxiety Disorder-7 items, GAD-7) 
and panic-attack (“In the last 4 weeks, have you had an 
anxiety attack – suddenly feeling fear or panic?”) [16] as 
previously described [17]. Total 81 HF patients with a 
positive screen for depression, anxiety, or panic attack were 
referred for further assessment from 404 eligible HF 
patients. 73 referred patients underwent structured 
psychiatric interview to determine disorder onset, 
comorbidities, and treatment needs. At this time, the PHQ-9, 
GAD-7 and panic-attack screening question were repeated.  
The post-traumatic stress disorder module of the 
Structured Clinical Interview for DSM-IV Axis-I disorders 
[18] was used to classify trauma(s) exposure, and other 
disorders including personality disorders [18, 19]. Diagnoses 
were made for treatment purposes and verified by two senior 
clinical psychologists once per month. For the purposes of 
this research, PTSD was categorized according to the trauma 
type preceding PTSD onset, classified as cardiac or non-
cardiac.   
 
2.3 Medical comorbidities  
HF etiology was determined from medical records 
and the HFSMP nurse practitioner who referred each patient 
(blinded to trauma exposure). The clinical presentation of 
HF at the most recent hospital admission preceding the 
psychiatric interview was classified consistent with the 
European Society of Cardiology [15]. Comorbidities and 
hospitalization data were classified according to 
International Classification of Diseases and Related Health 
Problems 10th Revision criteria [20] and extracted from 
electronic medical records and data linkage between 
hospitals, blinded to psychiatric history. The methods for 
audit of cardiac events is reported elsewhere [21].  
 
2.4 Statistical analyses  
Data analyses were performed with SPSS® 24.0 (IBM Corp. 
Armonk, NY). Descriptive comparisons between cardiac and 
non-cardiac PTSD employed the independent samples t-test, 
and the chi-square statistic with Fisher’s exact test as 
appropriate. All statistical tests were two-tailed, an alpha 
value p<.05 was considered statistically significant. Since 
this study was exploratory, where Type II errors are more 
important to avoid, no adjustment was made for multiple 
comparisons [22]. 
3. RESULTS  
From 73 HF patients assessed, 28 patients (38.4%) 
met criteria for PTSD or adjustment disorder. 10 patients 
meeting criteria for non-cardiac trauma were categorized as 
rape, sexual abuse, or intimate partner violence (n=7), 
witness a death or suicide (n=2), and witnessed inhumane 
slaughter of animals (n=1). 18 patients meeting criteria for 
cardiac-induced trauma were categorized according to HF-
hospitalization (n=12), myocardial infarction (n=3), sudden 
cardiac arrest (n=2), and coronary artery bypass grafting 
(n=1). 
There were no significant demographic differences 
between those with cardiac and non-cardiac PTSD (Table 1), 
nor differences in HF etiology, phenotype, or severity. Time 
since PTSD onset was significantly longer for those with 
non-cardiac PTSD. Other differences in psychiatric 
presentation included that the cardiac-PTSD patients were 
less likely to endorse the panic attack screening question 
during routine screening. Among psychiatric comorbidities, 
alcohol and substance abuse disorders, as well as depression 
were more prevalent in the patients with non-cardiac PTSD 
(Table 2). Otherwise, there were few differences between 
groups with regards to mental health including comorbid 
anxiety disorder or personality disorder, anxiety and 
depression symptom severity or mental health hospital 
admissions over 6 months. Longer term HF-related hospital 
admissions were similar in the cardiac and non-cardiac 
PTSD patients (Table 3).  
4. DISCUSSION 
This short report was among the first to compare 
cardiac and non-cardiac PTSD patients, suggesting few 
demographic and medical comorbidity differences between 
persons with cardiac-induced PTSD and their non-cardiac 
induced PTSD counterparts. Among psychiatric 
comorbidities, alcohol and substance abuse disorders, and 
depression were more prevalent in patients with non-cardiac 
induced PTSD. Cardiac trauma itself was more common 
than non-cardiac trauma in this HF population.  
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There is a limited body of literature suggesting that 
those with cardiac-induced PTSD are at greater risk for 
subsequent adverse CVD events and outcomes [1]. The 
present findings, however, indicate comparable CVD 
outcomes and severity regardless of trauma-type, suggesting 
that prognosis and course of HF may be similar. Further, no 
differences in cardiac admissions over 6 months were 
observed between groups. While it remains unclear whether 
cardiac-onset PTSD represents a distinct subtype of PTSD 
[5], our findings suggest that trauma type does not portend 
differences in CVD outcomes and thus may not represent 
different HF treatment needs.  
Significant differences between PTSD groups was 
observed with regards to psychiatric comorbidity. Non-
cardiac induced PTSD patients had higher rates of drug and 
alcohol disorders as well as depression, although depression 
symptom severity did not differ.  Substance use is common 
as self-medication for PTSD symptoms, frequently resulting 
in comorbid substance use disorders [23, 24] and increasing 
CVD risk [25]. Time since PTSD onset was significantly 
longer for those with non-cardiac PTSD, increasing duration 
of possible self-medication coping strategies and likelihood 
of resultant disorders. In the case of cardiac PTSD, onset 
likely occurs during a period where patients are engaged in 
cardiac rehabilitation, including education, guidance and 
monitoring regarding health and lifestyle factors, such as 
drug/alcohol use [26]. Hence, this subgroup may be less 
likely to self-medicate with drugs or alcohol post-PTSD 
onset. Further, higher prevalence of depression disorders was 
noted in the non-cardiac PTSD group and substance use 
disorders are more prevalent in those with comorbid 
depression and PTSD, than those with PTSD only [27]. 
Among risk factors for comorbid depression in PTSD are 
younger age [28] and childhood adversity or sexual abuse 
[29]. Within our sample, PTSD onset occurred at a younger 
age among the non-cardiac PTSD group, and a large 
proportion of non-cardiac traumas were sexual-abuse related. 
Thus, the higher rates of comorbid depression may reflect 
the posited childhood trauma phenotype of PTSD [30]. 
Therefore, although there were differences between cardiac 
and non-cardiac PTSD groups with regards to psychiatric 
comorbidity, this may not necessarily reflect a distinct 
cardiac-PTSD subtype and may be explained by other 
sample characteristics. 
Also evident from this study is that a proportion of 
cardiac patients experience PTSD only, with an absence of 
depression. Many cardiovascular guidelines recommend 
routine screening for depression [31-34], with PTSD not 
typically assessed in medical care [35]. Our findings indicate 
that the mental health needs of PTSD patients may not be 
identified or addressed in routine medical care if only 
depression screening is in place [36]. The HF nurse initiated 
HF screening results indicate that 10% of non-CVD induced 
and 40% of CVD-induced HF patients meeting criteria for 
PTSD would not be identified by depression-only screening. 
Such patients were likely identified by HFSMP nurses 
through anxiety and panic-attack screening. Further, the 
extant literature has largely focused on depression 
assessment and treatment in CVD, potentially to the neglect 
of other mental health needs such as PTSD and anxiety 
disorders [37]. Thus, how to best identify and support the 
mental health needs of the CVD population with PTSD 
(without depression) needs further exploration as do 
preventative efforts [38].  
 Despite that PTSD portends increased risk for 
poorer cardiac outcomes [2, 3] treatments for PTSD in CVD 
populations are poorly described [39] and treatment trials 
remain scant [35]. To date, trauma-focused cognitive 
behavioral therapy have shown reductions in PTSD 
symptoms [39-41], with one study addressing the safety of in 
vivo exposures for this population [39]. However, best 
practice in the treatment of PTSD in CVD populations and 
the suitability of existing treatments remains 
underdeveloped, with ongoing exploration needed to address 
cardiovascular response and safety [39, 42]. Further, whether 
a cardiac-induced PTSD subtype is supported by the 
evidence and represents differential PTSD treatment needs 
requires clarification. Considering that cardiac-related 
trauma was more common than non-cardiac trauma, our 
findings underscore the need for further clinical research in 
these populations.  
  This paper also extends understanding around 
PTSD in cardiac populations by highlighting the 
demographic, cardiac and psychiatric profile of HF patients 
with PTSD. The majority of extant literature has examined 
ACS, with course and outcomes of PTSD in other CVD 
presentations lesser reported. As many as 1 in 8 ACS 
patients are reported to develop PTSD [43], the present 
findings also highlight the presence of cardiac-related PTSD 
in a HF population with mixed CVD comorbidities. The 
CVD-induced PTSD group here had a range of precipitant 
factors including hospitalization, surgery, and sudden cardiac 
arrest. The findings here raise the possibility that 
hospitalization itself may be the triggering traumatic event 
for these patients and that the CVD cause is less important 
[44, 45]. 
 
4.1 Strengths and limitations 
  Strengths of this study include structured diagnostic 
interview, use of medical records for physical and cardiac 
health, and blinded assessment of HF etiology by qualified 
CVD practitioners. This study is presented with several 
limitations that limit the generalizability of this study. 
Chiefly, no comparison was made on PTSD severity 
between cardiac and non-cardiac induced PTSD. Though 
PTSD symptoms were quantified for therapeutic purposes, 
these data were unavailable for all patients and did not form 
the core battery of tests administered to patients in the initial 
HFSMP screen and psychiatric assessment. A related point is 
that identification of PTSD and related treatment needs is 
likely incomplete. Because screening for depression and 
anxiety any resultant identification of PTSD is contingent on 
patients attending HF appointments, highly avoidant patients 
with CVD-related trauma may not have attended 
appointments or participated in the HFSMP. Additionally, 
longer-term follow-up to ascertain cardiac outcomes and 
major adverse cardiac events beyond 6 months was not 
undertaken. Moreover, the sample was restricted to persons 
assessed for potential psychological treatment. It is possible 
that purely epidemiological studies in CVD patients, not 
associated with a mental health care component, would 
arrive at different findings related to CVD trauma sub-type 
and differences from non-CVD patients meeting criteria for 
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PTSD. A related point concerns the population referred for 
psychological treatment from 1 region in metropolitan 
Adelaide, which precludes generalization to other healthcare 
populations or diverse ethnic regions. Moreover, the size of 
the sample likely results in low statistical power to detect 
small to moderate differences, especially with regards to 
major adverse events and hospitalizations which require 
large samples [46].  
5. CONCLUSION  
 The present study identified minimal differences 
between cardiac and non-cardiac induced PTSD, especially 
with regards to CVD phenotype, severity or course over 6 
months; suggesting little difference in CVD treatment needs 
regardless of PTSD trauma type. Differences in psychiatric 
comorbidities may be explained by the childhood trauma 
phenotype, and timing of PTSD onset. Ongoing research is 
needed to further establish if cardiac-induced PTSD truly 
reflects a unique subtype of PTSD, and whether there are 
different treatment needs for this subtype.  
 
Current & Future Developments 
Cardiac-induced PTSD was recently proposed as a specific 
subtype of PTSD, posited to follow exposure to major 
cardiac events or cardiac diagnosis in some individuals. The 
ways in which PTSD symptoms and treatment needs differ 
between persons with and without cardiac trauma remain 
uncertain, questioning the need for a distinct subtype. 
Further research is required to validate whether cardiac-
induced PTSD is a distinct subtype from non-cardiac PTSD. 
Likewise, further research is required to compare cardiac-
induced PTSD with other types of medical trauma or major 
illness such as cancer.  
 
Availability of Data and Materials  
Because of the sensitive nature of the data collected for this 
study, requests to access the dataset from qualified 
researchers trained in human subject confidentiality 
protocols may be sent to Central Adelaide Local Health 
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Table 1: Demographic, cardiac and biomedical characteristics of heart failure patients grouped according to cardiac 
and non-cardiac PTSD 
 
Descriptive characteristic  Non-cardiac trauma  
N = 10 
Cardiac trauma  
N = 18 
P 
Age in years M ± SD 54.3 ± 12.5 61.5 ± 16.7 0.24 
Female sex 7 (70.0) 8 (44.4) 0.25 
Live alone 3 (30.0) 5 (27.8) 0.99 
Disability pension  3 (30.0) 3 (16.7) 0.63 
Employed 1 (10.0) 3 (16.7) 0.99 
Tobacco smoking 4 (40.0) 8 (44.4) 0.99 
Median age of HF onset, years (IQR) 0.7 (0.5 – 0.9) 0.7 (0.3 – 0.7) 0.99 
HF aetiology   0.99 
Ischemic  7 (70.0) 10 (55.6)  
Valvular - 2 (11.1)  
Viral 1 (10.0) 2 (11.1)  
Peripartum - 1 (5.6)  
Alcohol - 1 (5.6)  
Idiopathic   2 (20.0) 2 (11.1)  
HF phenotype   0.51 
Pulmonary edema  1 (10.0) 4 (22.2)  
Cardiogenic shock 2 (20.0) 1 (5.6)  
Decompensated HF 5 (50.0) 7 (38.9)  
Hypertensive  2 (20.0) 2 (11.1)  
Right HF - 2 (11.1)  
ACS-HF - 2 (11.1)  
NYHA class    0.76 
I - -  
II 3 (30.0) 7 (38.9)  
III 6 (60.0) 9 (50.0)  
IV 1 (10.0) 2 (11.1)  
Left ventricular ejection fraction % M ± SD 31.2 ± 12.0 34.3 ± 11.3 0.51 
Previous myocardial infarction  6 (60.0) 5 (27.8) 0.125 
Previous CABG or PCI 2 (20.0) 4 (22.2) 0.99 
Atrial arrhythmia  3 (30.0) 6 (33.3) 0.99 
Ventricular arrhythmia  1 (10.0) 1 (5.6) 0.99 
Sudden cardiac arrest  1 (10.0) 2 (11.1) 0.99 
Implantable cardioverter defibrillator  4 (40.0) 5 (27.8) 0.68 
Pacemaker  1 (10.0) 2 (11.1) 0.99 
Valvular regurgitation  - 2 (11.1) 0.52 
Hypertension 5 (50.0) 12 (66.7) 0.44 
Peripheral vascular disease - 1 (5.6) 0.99 
Chronic kidney disease 4 (40.0) 7 (38.9) 0.99 
Diabetes 3 (30.0) 10 (55.6) 0.25 
Lung disease 4 (40.0) 5 (27.8) 0.68 
Cerebrovascular disease  1 (10.0) 4 (22.2) 0.63 
Sleep apnea  1 (10.0) 3 (16.7) 0.99 
Data presented as N (%) unless otherwise noted.  
ACS, acute coronary syndrome; CABG, coronary artery bypass graft; HF, heart failure; IQR, interquartile range; NYHA, New 
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Table 2: Psychiatric characteristics of heart failure patients grouped according to cardiac and non-cardiac PTSD 
 Non-cardiac trauma  
N = 10 
Cardiac trauma  
N = 18 
P 
Results from routine screening       
Depression, PHQ-9 ≥10 9 (90.0) 11 (61.1) 0.19 
Anxiety, GAD-7 ≥ 7 9 (90.0) 11 (61.1) 0.19 
Panic attack symptoms (yes)  9 (90.0) 6 (33.3) 0.006 
Psychiatric interview and assessment      
Median PTSD duration in years, IQR 7 (2-34)  1 (0-1) <0.001 
Depression disorder1 10 (100.0) 6 (33.3) 0.001 
Anxiety disorder2 9 (90.0) 13 (27.2) 0.28 
Alcohol abuse/dependence  6 (60.0) 2 (11.1) 0.011 
Substance abuse/dependence  4 (40.0) 1 (5.6) 0.041 
Personality disorder  5 (50.0) 2 (11.1) 0.063 
Depression symptoms (PHQ-9) M ± SD 15.1 ± 7.0  12.2 ± 8.1 0.35 
Anxiety symptoms (GAD-7) M ± SD 13.8 ± 5.9 11.1 ± 7.6 0.34 
1. Depression inclusive of major depression, dysthymia, bi-polar; 2. Anxiety disorder inclusive of generalized anxiety disorder, 
panic disorder, agoraphobia, social anxiety disorder, obsessive compulsive disorder (excluding post-traumatic stress disorder 
and adjustment disorder). GAD-7, Generalized Anxiety Disorder-7 items; IQR, inter-quartile range; PHQ-9, Patient Health 
Questionnaire-9 items; PTSD, post-traumatic stress disorder;  
 
 




N = 10 
Cardiac 
trauma  
N = 18 
P 
Pre-psychiatric interview    
HF admissions over 6 months  1 (0-2) 2 (1-3) 0.43 
HF admission LOS over 6 months 6 (0-18) 12 (1-15) 0.70 
Mental health admissions over 6 months  0 (0-0) 0 (0-0) 0.99 
Mental health admission LOS over 6  
months 
0 (0-0) 0 (0-0) 0.99 
Post-psychiatric interview    
HF admissions over 6 months  0 (0-0) 0 (0-0) 0.99 
HF admission LOS over 6 months 0 (0-2) 0 (0-1) 0.99 
Mental health admissions over 6 months  0 (0-0) 0 (0-0) 0.52 
Mental health admission LOS over 6  
months 
0 (0-0) 0 (0-0) 0.52 
HF, heart failure; LOS, length of stay;  
 
 
